CRISPR Therapeutics AG 10-K for FY2025
CRISPR Therapeutics AG (CRSP)
10-K
2026-02-12
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
CRISPR Therapeutics AG filed this 10-K on February 12, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.51M
- down 90.6% from $37.31M a year earlier
- Net loss
- $581.6M
- compared with a net loss of $366.25M a year earlier
- Diluted EPS
- -$6.47
- compared with -$4.34 a year earlier